ZK30-bioactive glass composites for orthopedic applications: A comparative study on fabrication method and characteristics

Previous in vivo studies on biodegradable magnesium alloys for orthopedic implant applications showed the need to improve early-stage bioactivity. Introducing bioactive particles into a magnesium alloy to form a metal matrix composite (MMC) represents an effective way to enhance the bioactivity of the alloy. In this study, composites with the ZK30 alloy as the matrix and the 45S5 bioactive glass (BG) as the reinforcement phase were fabricated using a semi-solid casting (SSC) method and a powder metallurgy (P/M) method. The SSC and P/M biocomposites with the same weight percents of bioactive glass particles were compared. Optical microscopy showed homogeneously dispered BG particles in the SSC and P/M composites. SEM and EDX analyses confirmed the retention of the morphological characteristics and composition of BG particles in the composites. However, the SSC composites exhibited micro-porous structures, while the P/M composites had nearly fully densified structures. As compared with the ZK30 matrix, the SSC composites exhibited significantly higher degradation rates, while the P/M composites possessed lower degradation rates. On the surface of all the composites, accelerated deposition of Ca and P ions occurred during immersion in the cell culture medium, indicating an improved surface bioactivity of the composites. The P/M method was found to be advantageous over the SSC method and could yield magnesium-matrix composites with enhanced corrosion resistance and early-stage bioactivity needed for biodegradable bone implants.

► Biodegradable Mg-bioglass composites were made using casting; powder metallurgy.
► Bioglass powder retained its composition and morphology.
► Accelerated deposition of Ca; P ions on composites occurred due to bioglass.
► Mg-bioglass composites made from powders had reduced degradation rates.
► Powder metallurgy appeared to be better for making biodegradable composites.